TIAZAC
Identification of Tiazac
| No description |
Google image searchProduct monograph
Active ingredient
diltiazem hydrochloride, 180 MG
DIN: 02231151
Dosage form(s): CAPSULE (EXTENDED RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: BAUSCH HEALTH, CANADA INC.
Date: 04-JUN-2021
ATC:
- C08 — CALCIUM CHANNEL BLOCKERS (ATC, ATC/DDD, )
- C08D — SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS (ATC, ATC/DDD)
- C08DB — Benzothiazepine derivatives (ATC, ATC/DDD)
- C08DB01 — DILTIAZEM (ATC/DDD)
Reference brand drug: Cardizem, Tiazac
Pharmaceutical standard: USP
